Patent · US Expired

6-triazolyl3-(trifluoromethyl)phenyl!methyl!-2-quinolines and -quinolinethiones

US5922734A · kind A · utility

0Cited by
5References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 1997
Grant dateJul 13, 1999
Priority date
Expiry dateJun 16, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/56
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention is concerned with the compounds of formula ##STR1## the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, PA1 wherein: R.sup.1 is hydrogen, amino or C.sub.1-4 alkyl; R.sup.2 is hydrogen, halo or C.sub.1-4 alkyl; R.sup.3 is hydrogen, halo or C.sub.1-4 alkyl; Y is 0 or S, and --X.sup.1 .dbd.X.sup.2 --is a bivalent radical having the formula --N.dbd.CH--(a-1) or --CH.dbd.N--(a-2); compositions containing the same, and processes of preparing these compounds. It further relates to their use as a medicine, in particular their use as a medicine to treat keratinization disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.